International Journal of Health & Allied Sciences

: 2015  |  Volume : 4  |  Issue : 1  |  Page : 3--8

Therapeutic strategies for multiple sclerosis: Current data

Anastasios M Georgiou 
 University of Sheffield, Medical School, Sheffield Institute of Translational Neuroscience, Sheffield, United Kingdom

Correspondence Address:
Anastasios M Georgiou
James Cook University, Division of Tropical Health and Medicine, Rehabilitation & Exercise Science Building 43, Room 137, Townsville, QLD 4811
United Kingdom

At present, the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have approved drugs for Relapsing Remitting Multiple Sclerosis (RRMS) and Secondary Progressive MS (SPMS). In this paper, modern therapeutic strategies for MS are reviewed. A comprehensive research in MEDLINE, PUBMED, and SCIENCEDIRECT databases using two Boolean phrases {i.e. 1. [(Multiple Sclerosis) and (Disease Modifying Therapies)] and 2. [(Multiple Sclerosis) and (Neuroprotective Therapies)]} yielded more than 1,5000 articles in total. Therefore, for the purposes of this paper, articles written within the last decade were considered for review.

How to cite this article:
Georgiou AM. Therapeutic strategies for multiple sclerosis: Current data.Int J Health Allied Sci 2015;4:3-8

How to cite this URL:
Georgiou AM. Therapeutic strategies for multiple sclerosis: Current data. Int J Health Allied Sci [serial online] 2015 [cited 2020 May 31 ];4:3-8
Available from:;year=2015;volume=4;issue=1;spage=3;epage=8;aulast=Georgiou;type=0